H. Stark et al., INVITRO PENETRATION OF ES-TYROSINE(1)-D-PHENYLALANINE(3)-BETA-CASOMORPHIN ACROSS THE BLOOD-BRAIN-BARRIER, Peptides, 13(1), 1992, pp. 47-51
The blood-brain barrier transport and metabolism of the synthetic beta
-casomorphin (beta-CM) derivative des-tyrosine1-D-phenylalanine3-beta-
casomorphin (DT-D-Phe3-beta-CM) were investigated using an in vitro mo
del consisting of primary cultures of bovine cerebrovascular endotheli
al cells. DT-D-Phe3-beta-CM was transported across the endothelial mon
olayer without significant metabolism. The endothelial permeability ex
pressing the transport rate ranged between 1.4 and 2.2 cm x 10(-3)/min
and was neither affected by luminal concentration changes (1 nM and 1
-mu-M) nor different after luminal and abluminal administration. The m
etabolic inhibitor 2-desoxy-D-glucose did not affect the permeability
of DT-D-Phe3-beta-CM. These results suggest that DT-D-Phe3-beta-CM is
able to cross the blood-brain barrier by paracellular transport withou
t using a carrier system.